浏览标题索引

标题 文件
编号 4 (2015) "Autoimmune" atypical hemolytic-uremic syndrome in a child - genetic carrier of multiple polymorphisms of hemostasis genes (clinical observation)
Semeshina O., Luchaninova V., Kozlovskaja N., Gorelik N., Mel'nikova E., Mankevich T., Stepanjuk V., Grivachevskaja A., Emirova H., Generalova G., Ibragimova E.
编号 2 (2012) DIFFICULT NEPHROLOGICAL PATIENT TODAY
Mukhin N., Moukhin N.
编号 2 (2011) PATIENT TRAINING AS AN APPROACH TO ENHANSING OF TREATMENT COMPLIANCE IN RENAL ARTERIAL HYPERTENSION
Borovkova N., Borovkov N., Khor'kina Y., Maslova T., Pakhomova T.
编号 2 (2010) 100 year anniversary of Kakovsky-Addis test
- -.
编号 4 (2009) 100-letie "Klinicheskikh lektsiy" G.A. Zakhar'ina
Lazebnik L.
编号 4 (2009) 40-TH YEAR ANNIVERSARY OF ALLUNION SCIENTIFIC SOCIETY OF NEPHROLOGISTS - RUSSIAN SCIENTIFIC SOCIETY OF NEPHROLOGY
Androsova S.
编号 2 (2009) 90-LET S MOMENTA OPISANIYa SINDROMA GUDPASChERA
- -.
编号 3 (2018) ANCA-associated rapidly progressive glomerulonephritis
Frolova N.
编号 2 (2010) Calcinosis of abdominal aorta in chronic kidney disease patients, not receiving renal replacement therapy
Volkov M., Smirnov A., Degtereva O., Kirillova E., Gordeeva L., Volkov M., Smirnov A., Degtereva O., Kirillova E., Gordeeva L.
编号 4 (2009) CLINICAL SIGNIFICANCE OF DETERMINATION OR URINARY CONCENTRATION OF ENDOTHELIAL DYSFUNCTION AND FIBROGENESIS MARKERS IN HYPERTENSIVE NEPHROPATHY
Nanchikeeva M., Kozlovskaya L., Fomin V., Bobkova I., Rameev V., Nanchikeeva M., Kozlovskaya L., Fomin V., Bobkova I., Rameev V.
编号 2 (2010) Comparison of distribution of erythropoietin medications isoforms with two-dimensional gel-electrophoresis
Shnaider A.
卷 14, 编号 1 (2022) COVID-19 and viral dermal diseases in patients after renal transplantation
Dymkov I., Perlina A., Terentiev I., Prokopenko E., Kulikov P., Perlin D.
卷 13, 编号 4 (2021) COVID-19 and kidney damage
Mikhailova L., Sheleg D., Bogachev R.
编号 4 (2011) Specific adipokines in children with steroid-resistant nephrotic syndrome
Kulina E., Osmanov I., Vozdvizhenskaya E.
编号 2 (2010) Early markers of diabetic nephropathy
Bondar' I., Klimontov V., Bondar I., Klimontov V.
编号 3 (2011) Efficacy of aggressive immunosuppressive therapy in patient with fulminant Shoenlein-Henoch purpura
Gulyaev S., Meshkov A., Novikov P., Semenovykh A., Nikiforova N., Nosova N.
编号 3 (2018) ERA-EDTA-2018: recent developments in the treatment of MCN-CKD
- -.
编号 3 (2009) Frequently asked questions about glomerular filtration rate
Arutyunov G., Oganezova L., Aroutiunov G., Oganesova L.
编号 4 (2009) FROM SARALASIN TO SARTANS: HISTORY OF THE ANGIOTENSIN II RECEPTOR BLOCKADE
Fomin V., Kurashov M., Fomin V., Kurashov M.
编号 4 (2009) GOODPASTURE SYNDROME: FEATURES OF PATHOGENESIS, APPROACHES TO THE DIAGNOSIS AND TREATMENT
Mukhin N.
编号 2 (2011) HCV-associated cryoglobulinemic vasculitis with severe kidney involvement and B-cell lymphoma development. Monoclonal anti-CD-20 antibodies and antiviral therapy as options of prognosis improvement
Mukhin N., Kozlovskaya L., Milovanova L., Tegay S., Gordovskaya N., Ignatova T., Kudlinskiy I.
编号 2 (2014) IgM-NEPHROPATHY
Batiushin M., Pasechnik D., Chistiakov V.
卷 13, 编号 1 (2021) KIM-1 as the biomarker of acute kidney injury in patients with the acute coronary syndrome and oncological diseases
Mikhailova Z., Pivovarov D., Rumyantseva S., Pivovarova A.
编号 1 (2010) LOOP DIURETICS AND ANTIHYPERTENSIVE TREATMENT: FORGOTTEN PAST OR REAL PERSPECTIVE?
Moiseev S., Fomin V., Moiseev S., Fomin V.
编号 4 (2009) NA+-K+-2CL-TRANSPORTER OF HENLE LOOP AS A TARGET FOR THE PHARMACOLOGICAL INTERVENTION
- -.
编号 2 (2018) NGAL - marker of subclinical acute kidney injury in patients with acute coronary syndrome
Shalenkova M., Mikhailova Z., Klimkin P.
卷 13, 编号 4 (2021) NGAL as a marker of acute kidney injury in sepsis
Sharipova V., Berdiev N., Lutfullaev O., Zhabborova M.
编号 4 (2009) PECULIARITIES OF AMBULATORY BLOOD PRESSURE MONITORING IN PATIENTS WITH ARTERIAL HYPERTENSION STAGES I - II WITH URIC ACID METABOLISM ABNORMALITIES
Donskov A.
编号 4 (2009) POTENTIALS OF ANGIOTENSIN II RECEPTOR BLOCKERS IN HALTING THE PROGRESSION OF RENAL TRANSPLANT NEPHROPATHY
Maksimov M.
编号 3 (2009) Problems of nephrology in 100-year history of Russian Scientific Medical Society of Internists
Kokorin V., Kokorina M., Kokorin V., Kokorina M.
编号 2 (2009) Renal expression of hypoxia-induced factor-1, anemia and nephrosclerosis severity in chronic glomerulonephritis
Shvetsov M., Ivanov A., Popova O., Kuznetsova A., Rameeva A., Shvetsov M., Ivanov A., Popova O., Kuznetsova A., Rameeva A.
编号 2 (2010) Renal oedema pathogenesis
Tareev E., Ratner N., Tareev E., Ratner N.
编号 1 (2010) TO WHAT LEVEL WE MUST DECREASE SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS NOT SUFFERING FROM TYPE 2 DIABETES MELLITUS?
Fomin V., Razuvaeva M., Fomin V., Razuvaeva M.
编号 2 (2010) Use of rituximab in severe ANCA-associated vasculitis
Mukhin N., Semenkova E., Krivosheev O., Novikov P., Moukhin N., Semenkova E., Krivosheev O., Novikov P.
编号 2 (2013) Errent classification of systemic vasculitides: recommendations of International consensus conference (Chapel Hill 2012)
Moiseev S., Semenkova E., Novikov P.
编号 4 (2017) Algorithms for the treatment of secondary hyperparathyroidism in patients with CKD stage 5D
Volgina G., Mikhailova N., Shutov E., Kotenko O.
卷 12, 编号 3 (2020) Aleksey Yur'yevich Nikolayev
- -.
编号 1 (2009) Allopurinol: indications and tactics of prescription
Lebedeva M.
编号 1 (2009) Albuminuria as a marker of kidney injury and cardiovascular risk
Mukhin N., Arutyunov G., Fomin V., Mukhin N., Arutyunov G., Fomin V.
编号 3 (2009) Albuminuria, plasma endothelin-1 and carotid atherosclerosis in patients with arterial hypertension and hyperuricemia
Lebedeva M., Stakhova T., Balkarov I., Minakova E., Zaytseva L., Severova M., Shovskaya T., Lebedeva M., Stakhova T., Balkarov I., Minakova E., Zaitseva L., Severova M., Shovskaya T.
编号 4 (2017) Analysis of the effect of markers of kidney injury related to the carbohydrate metabolism disorders on the risk of non-selective proteinuria
Ustinova M., Batiushin M.
卷 17, 编号 1 (2025) Analysis of demographic, clinical and laboratory parameters in COVID-19 patients with acute kidney injury
Abdurakhimov A.
编号 4 (2011) Growth retardation and body mass deficiency in children with chronic kidney disease stage II - V (Russian registry of children with chronic renal failure)
Molchanova M., Petrosyan E., Kazymova S., Molchanova E.
卷 14, 编号 4 (2022) Analysis of satisfaction with drug therapy for anemia in patients with stage 5 chronic kidney disease on hemodialysis
Kotenko O., Abolyan L., Kuteinikov V., Vinogradov V., Dorofeeva E.
卷 15, 编号 4 (2023) Analysis of functional results of surgical treatment of kidney cancer
Popov S., Guseynov R., Yesayan A., Sivak K., Perepelitsa V., Sadovnikova A., Grushevsky R., Lelyavina T.
编号 3 (2013) Prevalence of metabolic syndrome in early perioperative period after renal tranplantation
Zagorodnikova N., Rzhevskaya O., Lazareva K., Shmarina N., Pinchuk A.
编号 3-4 (2016) Angiomyolipoma of own recipient’s kidney after allotransplantation of cadaveric kidney
Yankovoy A., Sinyutin A., Stepanov V.
编号 6 (2011) Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta
Fomin V., Kozlovskaya L., Milovanov Y.
编号 3 (2013) Anticoagulation on haemodyalisis: perspectives of low molecular weight heparins in dyalisis optimization
Vishnevskiy K., Zamchenkov A., Gerasimchuk R.
编号 3 (2013) Antioxidants in nephrology: bardoxolone and diabetic nephropathy
- -.
卷 15, 编号 4 (2023) Arterial hypertension in kidney transplantation – modern therapy strategy
Nosov V., Koroleva L., Solovyanova E.
编号 6 (2011) JACCOUD'S ARTHRITIS IN PATIENT WITH TERMINAL LUPUS NEPHRITIS
Ermolenko V., Zakharova E., Malkoch A., Vinogradova O., Tareeva A.
编号 5 (2013) Asimmetry in inborn kidney hypoplasy and children viability in dependence of affection lateralization
Botvin'ev O., Safonova M.
卷 14, 编号 4 (2022) Assotsiatsiya «Professional'naya assotsiatsiya nefrologov»
- -.
卷 13, 编号 2 (2021) Association of nephrolitiasis with arterial hypertension: gender specificities of comorbidity pathogenesis
Barinov E., Grigoryan K., Malinin Y.
编号 5-6 (2012) Association of gene of glucocorticoid receptor polymorphism in children with steroid-resistant nephrotic syndrom
Resnikov A., Tikhomirov E., Gavrilova V., Yurasova Y., Petrosian E.
编号 1 (2016) Association of polymorphic markers of TNF, IL 6 and IL10 genes with the clinical and morphological features of chronic glomerulonephritis
Kamyshova E., Shvetsov M., Burdennyi A., Chzhen A., Kutyrina I., Nosikov V.
编号 3 (2014) Vasoactive hormones gene polymorphism and myocardial remodeling in chronic glomerulonephritis
Kamyshova E., Shvetsov M., Kutyrina I., Rudenko T., Nosikov V.
编号 5-6 (2012) Association of prehypertension with risk factors of chronic kidney disease, arterial hypertension and atherosclerosis
Burmagina A., Nikolaev A.
卷 13, 编号 4 (2021) Association of proteolysis factors with progression of autosomal dominant polycystic kidney disease in children
Bashirova Z., Osmanov I.
编号 1 (2009) Atherosclerotic stenosis of the sole functioning kidney artery in patient with diabetes mellitus type 2 as a variant of kidney multimorbidity inelderly
Mukhin N., Shilov E., Fomin V., Moiseev S., Shvetsov M., Yurkevich L., Mukhin N., M Shilov E., Fomin V., Moiseev S., Shvetsov M., Yurkevich L.
编号 3-4 (2016) Pregnancy-associated atypical hemolytic uremic syndrome: life-saving therapy with ekulizumab
Prokopenko E., Likhvantsev V., Vatazin A., Lopatin A., Guryeva V., Ostrovsky E., Fomin A., Ulitkina O.
编号 2 (2015) Atypical hemolytic uremic syndrome in pregnancy and hellp-syndrome. Differential diagnosis
Batjushin M.
编号 3 (2011) Autosomal-dominant polycystic kidney disease: perspectives of treatment
- -.
编号 1 (2015) Protein-energy malnutrition in peritoneal dialysis patients: risk factors and diagnosis
Vetchinnikova O., Pichugina I.
编号 6 (2010) BENCE JONES PROTEIN
- -.
卷 12, 编号 4 (2020) Bendopnea as a predictor of CHF decompensation in patients with CKD and COVID-19
Dragunov D., Sokolova A., Latyshev T., Arutyunov G.
编号 1 (2016) Pregnancy in a patient with renal tubular acidosis (clinical observation): management strategy, delivery and correction of metabolic disorders
Upryamova E., Nikol'skaya I., Prokopenko E., Novikova S., Samko A., Bocharova I., Budykina T.
编号 2 (2009) Beta-blockers and renal continuum
Arutyunov G., Oganezova L., Arutyunov G., Oganezova L.
卷 16, 编号 2 (2024) Biological significance of differentially expressed genes in hypoxic-ischemic acute kidney injury
Popov S., Guseinov R., Yesayan A., Skryabin O., Vasin A., Kovalevskaya A., Perepelitsa V., Beshtoev A., Lelyavina T.
编号 4 (2014) Renal damage in patients with arterial hypertension and hyperuricemia: personalised approach to prognosis
Muhin N., Kozlovskaya L., Fomin V., Stahova T., Lebedeva M., Balkarov I.
编号 1 (2015) Biomarkers for risk stratification in patients with atrial fibrillation and chronic kidney disease
Fomin V., Kijakbaev G.
编号 5 (2014) Biometric predictors of kidney remodeling in pregnant women
Konyshko N., Morozova T.
编号 2 (2018) The beneficial effect of fish oil on the idiopathic hypercalciuria in children
Mikheeva N., Zverev Y., Vykhodtseva G., Lobanov Y.
卷 11, 编号 3 (2019) Immediate results of endovascular correction of renal artery stenosis
Popov D., Solodushkin S., Stolyar A., Shardina L., Shardin S.
编号 5 (2010) ANGIOTENSIN II RECEPTOR BLOCKER VALSARTAN AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ENALAPRIL IN HYPERTENSIVE PATIENTS WITH RENAL TRANSPALANT NEPHROPATHY
Maksimov M.
编号 1 (2012) Angiotensin II receptor blocker valsartan and endothelial function in patients with chronic heart failure
Gyamdzhyan K., Maksimov M., Kukes V., Giamdjan K., Maksimov M., Kukes V.
编号 3 (2010) Angiotensin II receptor blockers in arterial hypertension: when to start?
- -.
编号 1 (2010) BERGER DISEASE
- -.
编号 3 (2010) Bright disease
- -.
编号 4 (2010) Bolezn' i smert' Mastera (o bolezni Mikhaila Bulgakova)
Dvoretskiy L.
卷 15, 编号 2 (2023) Castleman's disease associated with amyloidosis. Literature review and clinical observation
Frolova N., Varyasin V., Volgina G., Sysoeva I., Mudarisov R., Usatyuk S., Dyakova E., Stolyarevich E.
编号 5 (2011) de Toni-Debre-Fanconi disease (syndrome)
- -.
编号 5 (2010) Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
Fomin V., Pulin A., Rameev V., Sedov V., Meshkov A., Roshchupkina S., Panasyuk V., Kozlovskaya L., Mukhin N.
编号 1 (2018) Fabry disease: the main target organs in adults. Literature review
Firsov K., Kotov A.
卷 14, 编号 2 (2022) Rapid elimination of small stones from the middle third of the ureter: mechanisms of modulation of contraction and relaxation of smooth muscle tissue
Barinov E., Malinin Y., Grigoryan K.
编号 1 (2009) Heart rate variability, plasma renin activity and aldosterone level in chronic glomerulonephritis with arterial hypertension and normal renal function
Borovkova N., Borovkov N., Sidnev B., Obukhova E., Borovkova N., Borovkov N., Sidnev B., Obuhova E.
编号 2 (2011) Variants of the lupous nephritis course
Tareeva I.
编号 5-6 (2012) Renal function parameters and endothelial disfunction in patients with arterial hypertension
Rebrov A., Kuklina A.
编号 2 (2017) Relationship of hyperchemerinemia and parameters of nutritive status in patients with chronic renal insufficiency
Poganeva V., Batyushin M., Efimenko L.
卷 12, 编号 1 (2020) The relationship between the concentration of fibroblast growth factor-23 and central hemodynamics in patients with chronic kidney disease
Murkamilov I.
编号 6 (2013) Interrelations between natriuresis, central hemodynamics parameters and plasma angiotensin II concentration
Arutiunov G., Dragunov D., Sokolova A.
编号 1 (2015) Relationship of renal excretory function impairment to serum erythropoietin level in chronic heart failure
Makarova N., Zaharov J.
编号 1 (2011) ASSOCIATION OF LEPTINEMIA AND ADIPONECTINEMIA WITH CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE
Severova M., Saginova E., Gallyamov M., Ermakov N., Rodina A., Severov M., Fomin V., Mukhin N.
卷 12, 编号 1 (2020) The relationship of bendopnea and change in renal filtration function in patients with chronic heart failure
Dragunov D., Sokolova A., Gasanova A., Arutyunov G.
卷 13, 编号 1 (2021) Relationship between tumor necrosis factor alpha and interleukin-10 and left ventricular remodeling in renal failure
Murkamilov I., Sabirov I., Fomin V., Murkamilova Z., Kudaibergenova I., Yusupov F.
编号 6 (2014) A look at 175 years ago (B.Braun)
- -.
编号 4 (2010) VICh-ASSOTsIIROVANNAYa NEFROPATIYa: STRATEGIYa DIAGNOSTIKI I LEChENIYa
Mukhin N., Fomin V.
卷 12, 编号 4 (2020) The contribution of A.M. Shumlyansky (1748-1795), one of the founders of nephrology and microscopic anatomy in Russia, into clinical medicine (on the 225th anniversary of the death of the professor)
Morgoshiya T., Belyaeva D.
编号 4 (2014) S.S. Zimnitsky contribution in development of nephrology in Russian Federation
Maksudova A., Bombina L., Abdulganieva D., Nazarov M.
1 - 100 的 915 信息 1 2 3 4 5 6 7 8 9 10 > >>